Closely observe patients for extrapyramidal symptoms (EPS), including acute dystonia, akathisia, and parkinsonism. Document severity using a standardized scale like the Barnes Akathisia Rating Scale or the Simpson-Angus Scale. Administer anticholinergic medication as needed to manage EPS. Regularly assess for tardive dyskinesia using the Abnormal Involuntary Movement Scale (AIMS).
Monitor vital signs, particularly blood pressure and heart rate, frequently, especially during the initial treatment phase. Report any significant changes immediately to the prescribing physician. Maintain hydration. Observe patients for signs of neuroleptic malignant syndrome (NMS), including fever, muscle rigidity, altered mental status, and autonomic instability. Immediate medical attention is critical if NMS is suspected.
Regularly assess for changes in mental status, including sedation, confusion, and hallucinations. Document observations clearly and concisely. Evaluate the patient’s response to treatment in terms of symptom reduction and any adverse effects. Adapt the dosage regimen as advised by the physician based on the patient’s response and tolerance.
Conduct regular electrocardiograms (ECGs), especially for patients with pre-existing cardiac conditions. Observe for prolonged QT interval. Regular blood tests, including complete blood counts (CBCs) and liver function tests (LFTs), should be scheduled to detect any potential hematological or hepatic abnormalities. Carefully review the patient’s medical history and identify any potential drug interactions. Maintain open communication with the patient and family about the treatment plan and potential side effects.
Remember: This information is for educational purposes only and should not replace professional medical advice. Always follow your physician’s instructions and guidelines for administering and monitoring haloperidol lactate injection.
